Literature DB >> 3881346

Activation of the alternative complement pathway by pneumococcal lipoteichoic acid.

D S Hummell, A J Swift, A Tomasz, J A Winkelstein.   

Abstract

Cell wall teichoic acids of some gram-positive bacteria are potent activators of the alternative pathway of complement. It is unclear, however, whether the other form of teichoic acid, cell membrane lipoteichoic acid (LTA), can also activate the alternative pathway. In the present study, radiolabelled pneumococcal LTA was found to bind spontaneously to sheep erythrocytes in a temperature- and time-dependent fashion. In addition, the presence of pneumococcal LTA on the erythrocyte surface was verified by the fact that they could be agglutinated by a myeloma protein (TEPC-15) specific for choline, a constituent of pneumococcal LTA. Pneumococcal LTA when fixed to the surface of erythrocytes was able to activate the alternative pathway of complement in both guinea pig serum deficient in the fourth component of complement and human serum deficient in the second component of complement, resulting in lysis of the sensitized erythrocytes. The sensitizing principle of the LTA preparation was removed before erythrocyte sensitization by immunoabsorption, using the choline-specific TEPC-15 myeloma protein. These data demonstrate that purified pneumococcal LTA will bind to sheep erythrocytes and endow them with the ability to activate the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3881346      PMCID: PMC263180          DOI: 10.1128/iai.47.2.384-387.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Activation of the alternative pathway by pneumococcal cell walls.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

2.  Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid.

Authors:  J A Winkelstein; A Tomasz
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

3.  Activation of the alternative complement pathway by a streptococcal lipoteichoic acid.

Authors:  B A Fiedel; R W Jackson
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

4.  Cellular metabolism in genetic transformation of pneumococci: requirement for protein synthesis during induction of competence.

Authors:  A Tomasz
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

Review 5.  Lipoteichoic acids: a new class of bacterial antigen.

Authors:  A J Wicken; K W Knox
Journal:  Science       Date:  1975-03-28       Impact factor: 47.728

6.  Pneumococcal Forssman antigen. A choline-containing lipoteichoic acid.

Authors:  E B Briles; A Tomasz
Journal:  J Biol Chem       Date:  1973-09-25       Impact factor: 5.157

7.  Synthesis and excretion of glycerol teichoic acid during growth of two streptococcal species.

Authors:  R Joseph; G D Shockman
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

8.  Activation of complement by cell surface components of Staphylococcus aureus.

Authors:  B J Wilkinson; Y Kim; P K Peterson; P G Quie; A F Michael
Journal:  Infect Immun       Date:  1978-05       Impact factor: 3.441

9.  Genetically controlled total deficiency of the fourth component of complement in the guinea pig.

Authors:  L Ellman; I Green; M Frank
Journal:  Science       Date:  1970-10-02       Impact factor: 47.728

10.  Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.

Authors:  J W Tauber; M J Polley; J B Zabriskie
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Pneumococcal wall teichoic acid is required for the pathogenesis of Streptococcus pneumoniae in murine models.

Authors:  Hongmei Xu; Libin Wang; Jian Huang; Yanqing Zhang; Feng Ma; Jianmin Wang; Wenchun Xu; Xuemei Zhang; Yibing Yin; Kaifeng Wu
Journal:  J Microbiol       Date:  2015-01-28       Impact factor: 3.422

3.  Bacterial lipoteichoic acid sensitizes host cells for destruction by autologous complement.

Authors:  D S Hummell; J A Winkelstein
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

Review 4.  Lipoteichoic acid and lipids in the membrane of Staphylococcus aureus.

Authors:  W Fischer
Journal:  Med Microbiol Immunol       Date:  1994-05       Impact factor: 3.402

5.  The ability to sensitize host cells for destruction by autologous complement is a general property of lipoteichoic acid.

Authors:  B D Weinreb; G D Shockman; E H Beachey; A J Swift; J A Winkelstein
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

6.  Stimulation of monokine production by lipoteichoic acids.

Authors:  S Bhakdi; T Klonisch; P Nuber; W Fischer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 7.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  Structural reevaluation of Streptococcus pneumoniae Lipoteichoic acid and new insights into its immunostimulatory potency.

Authors:  Nicolas Gisch; Thomas Kohler; Artur J Ulmer; Johannes Müthing; Thomas Pribyl; Kathleen Fischer; Buko Lindner; Sven Hammerschmidt; Ulrich Zähringer
Journal:  J Biol Chem       Date:  2013-04-19       Impact factor: 5.157

9.  Interaction of purified lipoteichoic acid with the classical complement pathway.

Authors:  M Loos; F Clas; W Fischer
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

10.  Heterogeneity of lipoteichoic acid detected by anion exchange chromatography.

Authors:  K Leopold; W Fischer
Journal:  Arch Microbiol       Date:  1992       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.